Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Articles by Don Long

Bioheart IPO will seek $46.9M to back cell therapy for heart

Medtronic gets new questions, big patent penalty, lawsuit

Device makers should be wary of tougher FDA drug powers

New Cypher vs. Taxus vs. BMS study not great news for DES

More than sacrifices, med-tech can contribute its innovations

ICD registry points to clear need for implant procedure training

SCAI issues new SCAAR data, now confident in DES safety

SCAAR likely (or maybe not) to remove scar on DES future

Boston Scientific: a buyout very much looking to happen?

For Boston Scientific.... Two-month Odyssey of restructuring not likely to end soon

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

In muscular dystrophies, gene therapies race the clock

‘Evo’ AI can design complete genomes